(Q44472977)

3 December 2017

title

Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE). (English)

1 reference

3 December 2017

0 references

1

Dariush Mozaffarian

1 reference

3 December 2017

Regina Nye

2

1 reference

3 December 2017

Wayne C Levy

series ordinal

3

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

Journal of the American College of Cardiology

3 December 2017

published in

1 reference

3 December 2017

volume

41

1 reference

3 December 2017

issue

11

1 reference

3 December 2017

page(s)

1933-1939

1 reference

Trends in hospitalization for heart failure in Scotland 1980-1990.

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900425-X

7 January 2021

Increase in hospital admission rates for heart failure in The Netherlands, 1980-1993.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900425-X

7 January 2021

Trends in hospitalization and mortality for heart failure in Spain, 1980-1993.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900425-X

7 January 2021

Epidemiology and prevention of cardiac failure: Framingham Study insights

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900425-X

7 January 2021

Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900425-X

7 January 2021

Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900425-X

7 January 2021

Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900425-X

7 January 2021

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900425-X

7 January 2021

The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900425-X

7 January 2021

Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900425-X

7 January 2021

Effect of amlodipine on mode of death among patients with advanced heart failure in the PRAISE trial. Prospective Randomized Amlodipine Survival Evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900425-X

7 January 2021

THE ROLE OF CYTOKINES IN THE FAILING HUMAN HEART

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900425-X

7 January 2021

Pathophysiological role of cytokines in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900425-X

7 January 2021

Endotoxin and immune activation in chronic heart failure: a prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900425-X

7 January 2021

Blood Transfusion in Elderly Patients with Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900425-X

7 January 2021

Pathophysiology of anaemia: focus on the heart and blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900425-X

7 January 2021

The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900425-X

7 January 2021

Analysis of heart morphology and function following erythropoietin treatment of anemic dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900425-X

7 January 2021

Cardiovascular consequences of correction of the anemia of renal failure with erythropoietin.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900425-X

7 January 2021

10.1016/S0735-1097(03)00425-X

Identifiers

DOI

1 reference

3 December 2017

1 reference